治疗动脉样硬化的纳米疗法:向,催化和能量转导
Yuqi Yang1, Jingguo Qu1, Tonghuan Xiao1
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
Advanced healthcare materials
|March 10, 2026
概括
先进的纳米医学为治疗动脉样硬化 (AS) 提供了新的希望. 本综述探讨了创新的纳米载体,纳米酶和能量传导平台,以精确地准动脉斑块并改善心血管疾病的结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 心血管医学 心血管医学
背景情况:
- 动脉样硬化 (AS) 是心血管死亡的主要原因.
- 目前针对AS的治疗方法面临的局限性包括生物可用性差,非向效应和斑块异质性.
- 纳米技术在克服AS这些治疗挑战方面具有独特的优势.
研究的目的:
- 系统地审查用于动脉样硬化管理的先进纳米治疗策略.
- 分析AS的创新纳米药物的设计,机制和疗效.
- 讨论纳米疗法在AS中的临床转化所面临的挑战和未来方向.
主要方法:
- 对三个核心纳米治疗策略的审查:针对性工程纳米载体,催化纳米酶和能量转换纳米平台.
- 对开创性研究进行批判性分析,重点关注设计理由,潜在机制和定量疗效.
- 材料创新与纳米医学的治疗进步的整合,用于AS.
主要成果:
- 针对目标设计的纳米载体通过先进的修改实现了病变特定的精度.
- 催化纳米酶通过清除活性氧物种 (ROS) 和调节脂质代谢来重新编程斑块微环境.
- 能量转换纳米平台使使用光,声和磁疗法进行物理干预成为可能.
结论:
- 纳米医学在克服目前动脉样硬化治疗的局限性方面具有显著的前景.
- 审查的策略表明了精确准和有效的斑块调节的潜力.
- 这项工作为纳米治疗药物在治疗动脉样硬化的临床转化绘制了一条道路.
相关概念视频
Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Peripheral Artery Disease III: Interprofessional Care
472
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472
Coronary Artery Disease V: Interprofessional Care
357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Atherosclerosis IV: Nursing Management
539
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
539
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K


